Market closed

Enzo Biochem/ENZ

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Enzo Biochem

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Ticker

ENZ

Trading on

NYSE

Industry

Health Care Providers & Services

Employees

185

Enzo Biochem Metrics

BasicAdvanced
$58M
Market cap
1.26
P/E ratio
$0.89
EPS
0.78
Beta
-
Dividend rate
$58M
0.78
$1.50
$0.99
60K
3.496
2.82
4.02
10.514
-15.07%
-12.77%
-39.90%
1.264
1.694
0.83
0.83
-1.307
-204.05%
-194.91%
-33.32%
221.37%

Enzo Biochem Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Enzo Biochem Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy ENZ

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Enzo Biochem stock?

Enzo Biochem (ENZ) has a market cap of $58M as of October 11, 2024.

What is the P/E ratio for Enzo Biochem stock?

The price to earnings (P/E) ratio for Enzo Biochem (ENZ) stock is 1.26 as of October 11, 2024.

Does Enzo Biochem stock pay dividends?

No, Enzo Biochem (ENZ) stock does not pay dividends to its shareholders as of October 11, 2024.

When is the next Enzo Biochem dividend payment date?

Enzo Biochem (ENZ) stock does not pay dividends to its shareholders.

What is the beta indicator for Enzo Biochem?

Enzo Biochem (ENZ) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.